• SinoMab BioScience will hold an extraordinary general meeting in Central, Hong Kong on Sept. 7, 2026.
• Shareholders will vote on the proposed disposal of the group’s Suzhou property and manufacturing facility.
• The transaction values the disposal at RMB 280 million in cash, with proceeds earmarked mainly to repay about RMB 230 million of bank borrowings.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SinoMab BioScience Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260821-12293408), on August 20, 2026, and is solely responsible for the information contained therein.